Neslihan Üstündağ Okur | Pharmaceutical Technology | Best Researcher Award

Prof. Dr. Neslihan Üstündağ Okur | Pharmaceutical Technology | Best Researcher Award

Prof. Dr. Neslihan Üstündağ Okur | University of Health Sciences | Turkey

Prof. Dr. Neslihan Üstündağ Okur is a distinguished scholar in pharmaceutical technology with a career dedicated to advancing innovative drug delivery systems. She earned her Bachelor of Pharmacy, Master’s degree, and PhD from Ege University, focusing her research on microemulsions, transdermal formulations, and ocular nano-carrier systems. Her academic journey has included roles as Research Assistant, Assistant Professor, Associate Professor, and currently Professor at the University of Health Sciences, Faculty of Pharmacy, where she also serves as Dean and Head of the Pharmaceutical Technology Department. She has held significant administrative positions at Istanbul Medipol University and has contributed extensively to the development of pharmaceutical formulations including microemulsions, solid lipid nanoparticles, in situ gels, dermal and ocular delivery systems, and sustained release technologies. Prof. Dr. Okur is actively engaged with professional organizations such as TÜFTAD, CRS, and ATINER. With a strong citation record and international recognition, she continues to shape pharmaceutical sciences globally.

Publication Profile

Google scholar

Educational Background

Prof. Dr. Neslihan Üstündağ Okur has pursued an impressive academic journey in pharmaceutical technology, building a strong foundation at Ege University. She completed her Bachelor of Pharmacy at the Faculty of Pharmacy, where she developed a deep interest in innovative drug delivery systems. Her academic path continued with a Master’s degree in Pharmaceutical Technology, where she focused on the in vitro and in vivo evaluation of transdermal microemulsion formulations containing naproxen, a study that highlighted her dedication to advancing therapeutic applications. She further strengthened her expertise by completing her doctoral research at the same institution, where her thesis explored the in vitro and in vivo evaluation of ocular nano-carrier systems containing antibiotics, contributing valuable insights into ocular drug delivery. This comprehensive academic background has laid the groundwork for her distinguished career, equipping her with advanced knowledge and innovative approaches in pharmaceutical sciences.

Professional Experience

Prof. Dr. Neslihan Üstündağ Okur has built an extensive career in pharmaceutical technology through progressive academic and administrative roles. She is currently serving as Professor at the University of Health Sciences, Faculty of Pharmacy, where she holds dual leadership positions as Dean of the Faculty of Pharmacy and Head of the Pharmaceutical Technology Department. Prior to this, she contributed as Associate Professor at the same institution, also leading the department with dedication. Her career includes valuable service at Istanbul Medipol University, where she held positions as Associate Professor and Vice Dean, and earlier as Assistant Professor and Head of the Pharmaceutical Technology Department. She began her academic journey at Ege University, serving first as a Research Assistant and later as Research Assistant with a doctoral focus, gaining deep expertise in drug delivery systems and pharmaceutical formulations. Throughout her career, she has demonstrated leadership, innovation, and a strong commitment to advancing pharmaceutical sciences.

Research Focus

Prof. Dr. Neslihan Üstündağ Okur’s research focus lies predominantly in the field of pharmaceutical technology, with particular emphasis on advanced drug delivery systems and innovative therapeutic formulations. Her work explores a wide range of drug carriers including polymeric systems, nano-structured lipid carriers, solid lipid nanoparticles, microemulsions, in situ gels, and composite films, targeting enhanced dermal, transdermal, and ocular drug delivery. She has made significant contributions to wound management through the development of polymeric carriers and novel dermal applications, as well as to ocular therapy with nanostructured platforms designed to improve bioavailability and treatment efficacy. Her studies further extend to anti-inflammatory and antifungal drug formulations, the use of stimuli-responsive nanoparticles, and nanotheranostic platforms for diagnostic and therapeutic purposes. By integrating in vitro and in vivo evaluations, she bridges experimental research with clinical applications, positioning her expertise at the intersection of pharmaceutical innovation, nanotechnology, and targeted drug delivery solutions.

Publication Top Notes

Recent trends on wound management: New therapeutic choices based on polymeric carriers
Year: 2020
Citations: 349

Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and uses
Year: 2016
Citations: 230

Current update on nanoplatforms as therapeutic and diagnostic tools: a review for the materials used as nanotheranostics and imaging modalities
Year: 2021
Citations: 180

Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations
Year: 2011
Citations: 149

Conclusion

Prof. Dr. Neslihan Üstündağ Okur is highly suitable for the Research for Best Researcher Award. Her innovative work in advanced drug delivery systems positions her as a leading figure whose contributions merit this recognition.

Pierre-Jean Pintard | Ophthalmology | Best Industrial Research Award

Dr. Pierre-Jean Pintard | Ophthalmology | Best Industrial Research Award

Medical Director at Abbvie, United Kingdom

👨‍⚕️ Dr. Pierre-Jean Pintard is a multilingual Medical Doctor based in London 🇬🇧, with expertise in Clinical Development, Medical Affairs, HEOR, and Pharmacovigilance. Currently Associate Global Medical Director at AbbVie, he has held key roles at Gilead, Bial, and Mylan. He holds an MD from Barts and The London, an MSc in Health Economics from LSE & LSHTM, and specialty training in Pharmaceutical Medicine. He has published in top journals and presented internationally. Fluent in French 🇫🇷, English 🇬🇧, and Spanish 🇪🇸, he is also a pianist 🎹 and certified sailing instructor ⛵.

Publication Profile

Google Scholar

Professional Experience

Dr. Pierre-Jean Pintard is a seasoned global medical leader with extensive experience across top pharmaceutical companies. Currently serving as Associate Global Medical Director at AbbVie 🌐, he leads clinical strategies and evidence generation for Ozurdex. At Gilead Sciences 🇪🇺, he played a pivotal role in maintaining access to Ambisome and launching Epclusa. Previously at Bial 🇵🇹, he managed global medical affairs for the inflammation portfolio. At Mylan 🇬🇧, he launched biosimilars and provided expert medical insights. Earlier roles at Bristol Myers Squibb and William Harvey Institute honed his skills in health outcomes research and clinical science 🔬📊

🎓 Educational Background

Dr. Pierre-Jean Pintard holds a diverse and interdisciplinary academic background. He completed Pharmaceutical Medicine Specialty Training (2019–2020) at NOVA Medical School/University of Aveiro, gaining expertise in protocol design, data analysis, and clinical monitoring 📊. He earned an MSc in International Health Economics and Policy (2016–2017) from LSE & LSHTM, focusing on pharma economics and cost-effectiveness 💶. His MD in Medicine (2011–2015) from Barts and the London included an elective in Kenya 🇰🇪 and a poster presentation at SCMR Nice. He also holds a BSc in Biomedical Sciences (2008–2011) from Queen Mary University, with emphasis on clinical trials and drug design 💊.

💼 Skills & Personal Interests

Dr. Pierre-Jean Pintard is a multilingual professional, fluent in French 🇫🇷 and English 🇬🇧, with proficiency in Spanish 🇪🇸 (C1), and basic knowledge of Portuguese 🇵🇹 and German 🇩🇪 (A2). His technical skills include MS Word, Excel (with Markov models), STATA, Zinc, Epi-Info, and Spotfire 💻. A passionate musician, he studied piano for 9 years at the Conservatoire of Marseille and earned 3rd prize at the Steinway & Sons championship 🎹. He is also an avid sailor ⛵ with 13 years of experience at Marseille Yachting Club and Docklands Sailing Centre, holding a sailing instructor license.

Research Focus

Dr. Pierre-Jean Pintard’s research spans across psychiatry, ophthalmology, and cardiology, reflecting a multidisciplinary focus. His early work explored mental health stigma among medical students 🧠. He has significantly contributed to ophthalmic research, especially in diabetic macular edema, identifying macular volume as a surrogate marker for visual acuity 👁️📊. In cardiology, he co-authored a study comparing cardiac MRI techniques for assessing left atrial volume, enhancing diagnostic precision ❤️🧲. His expertise lies in biomarker identification, clinical imaging, and evidence synthesis, highlighting a strong foundation in clinical research and health outcomes across multiple therapeutic areas.

Conclusion

Dr. Pierre-Jean Pintard is highly suitable for the Research for Best Industrial Research Award.
His industrially relevant clinical research, cross-functional leadership, international collaboration, and proven ability to drive patient-centric innovations align with the award’s objectives.

Publication Top Notes

📘 Medical students’ attitudes about mental illness – PJ Pintard et al. – 🗓️ 2012 – 📊 Cited by: 3 – 🧠🩺
📘 Anatomic biomarkers in diabetic macular edema: Macular volume as a surrogate for visual acuity – PJ Pintard et al. – 🗓️ 2025 – 📊 Cited by: [Data Pending] – 👁️📈
📘 Cardiac MRI techniques for left atrial volume measurement – PJ Pintard et al. – 🗓️ 2015 – 📊 Cited by: [Not Specified] – ❤️🧲